Related Topics
A powerful methodology to guide health decision-making
Launched in 2021, CAUSALab brings together 14 epidemiology faculty members across multiple universities to collaborate on applying causal inference methods to compare the effectiveness and safety of health and policy interventions in a broad range of areas.
Botswana lab known for identifying Omicron variant receives new recognition
When the lab of the Botswana Harvard AIDS Institute Partnership produced the first genetic sequence of the Omicron variant of the coronavirus in fall 2021, the world took notice. More recognition came last month when the lab was…
New treatment for children with HIV shows promise
Roger Shapiro, professor of immunology and infectious diseases, discusses his recent study of a new treatment option for children living with HIV.
Social support may help young adults living with HIV maintain viral suppression
Katherine Tassiopoulos, senior research scientist in the Department of Epidemiology, explains the findings of a recent study on social support and viral suppression among young adults living with HIV.
Victor De Gruttola’s storied career celebrated at biostatistics symposium
Members of the Department of Biostatistics recently gathered for a symposium celebrating the 50-year career of Victor De Gruttola, former chair and professor of biostatistics emeritus.
Timing of HIV treatment during pregnancy could affect developmental delays in children
During pregnancy, the timing of when mothers start taking antiretroviral drugs to treat HIV may impact the risk of developmental delays in children, according to a study co-authored by researchers at Harvard Chan School.
Strength in numbers
Octavious Smiley, PhD ’23, is dedicated to helping the next generation of minority students excel in the field of biostatistics.
PEPFAR program marks 20 years, 20 million lives saved
PEPFAR was the largest public health effort by one country against a single disease, and as of late last year, has provided lifesaving treatment to more than 20 million people suffering from HIV/AIDS.
New vaccine platform could aid in fight against deadly viruses
Researchers at Harvard Chan School have developed a new, highly adaptable vaccine platform that could potentially be a powerful tool in the fight against viral pathogens including influenza, HIV, and SARS-CoV-2.
Project uses geographic data to show that where a person lives matters to their health
Harvard Chan School's Nancy Krieger and colleagues have updated and broadened a project aimed at training people in how to track and monitor socially related disparities having to do with where a person lives.
